New Experimental Drug Promises Slow Memory Decline In Alzheimer’s Patients 05/12/2022 1 minute read Spread the love A total of 1795 patients were a part of this study. Out of the 898 were set to receive Lecanemab and 897 to receive placebo. About the Author View All Posts Post navigation Previous: asdfsdafNext: 4 passengers injured after bus overturns in Punjab’s Phagwara
